A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump.
Real-time continuous glucose monitoring and the insulin pump have been combined into the Sensor-Augmented Pump system (Medtronic MiniMed, Northridge, CA). This short-term pilot trial demonstrated that pediatric subjects with type I diabetes improved mean hemoglobin A1c (A1c) and glucose levels and reduced hypoglycemia and hyperglycemia using the Sensor-Augmented Pump system.
Halvorson
Mary
M
Division of Endocrinology and Metabolism, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA. mhalvorson@chla.usc.edu
Carpenter
Sue
S
Kaiserman
Kevin
K
Kaufman
Francine R
FR
D000293:Adolescent; D001786:Blood Glucose / Q000378:metabolism*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D004867:Equipment Design; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D015918:Infusion Pumps, Implantable; D007332:Insulin Infusion Systems; D010372:Pediatrics / Q000379:methods*; D010865:Pilot Projects
D001786:Blood Glucose; D006442:Glycated Hemoglobin